BridgeBio Pharma BBIO reported its Q3 earnings results on Thursday, November 3, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
BridgeBio Pharma beat estimated earnings by 6.06%, reporting an EPS of $-0.93 versus an estimate of $-0.99.
Revenue was down $2.01 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.18 which was followed by a 12.12% increase in the share price the next day.
Here's a look at BridgeBio Pharma's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.63 | -1.11 | -0.87 | -0.90 |
| EPS Actual | -0.81 | -1.19 | -1.01 | -1.06 |
| Revenue Estimate | 16.07M | 4.69M | 21.58M | 17.36M |
| Revenue Actual | 73.75M | 1.69M | 12.89M | 2.34M |
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for BridgeBio Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
